Oncology News and Research

RSS

Oncology, meaning bulk, mass, or tumor, and the suffix ''-logy'', meaning "study of") is a branch of medicine that deals with tumors (cancer). A medical professional who practices oncology is an ''oncologist''.

Takeda decides to terminate development of orteronel for prostate cancer

Takeda Pharmaceutical Company Limited announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the results of two Phase 3 clinical trials in metastatic, castration resistant prostate cancer (mCRPC).

19 Jun 2014

BIND Therapeutics inks research agreement with Roche to discover novel nanomedicines

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins, today announced that it has entered into a research agreement with Roche to discover novel nanomedicines using Accurins for the treatment of diseases in therapeutic areas outside of oncology.

19 Jun 2014

African American women with invasive breast cancer less likely to receive invasive technique

African American women with early stage, invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive a minimally invasive technique, axillary sentinel lymph node (SLN) biopsy, even as the procedure had become the standard of surgical practice, according to research from The University of Texas MD Anderson Cancer Center.

19 Jun 2014

NCCN Reimbursement Resource App now available for patients and caregivers

The National Comprehensive Cancer Network announces the availability of the NCCN Reimbursement Resource App, a free resource through which patients with cancer, providers, case managers, and payers can search for available reimbursement resources and patient assistance programs for multiple cancer types and supportive care indications.

19 Jun 2014

Generic drug delays cost U.S. payers millions

Problems surrounding an Indian company's launch of generic versions of three blockbuster drugs have preserved millions in revenue for the brand-name makers, reports The Wall Street Journal.

19 Jun 2014

Researchers develop device that spots lung cancer

Lung cancer causes more deaths in the U.S. than the next three most common cancers combined (colon, breast, and pancreatic).

19 Jun 2014

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

Janssen Pharmaceuticals, Inc.announced today that it has entered into an exclusive license agreement with Vertex Pharmaceuticals for the worldwide development, manufacturing and commercialization of VX-787, a novel medicine in Phase II development for the treatment of influenza A.

18 Jun 2014

First Edition: June 18, 2014

Today's headlines include a report that the cost of health law subsidies may push the measure's overall price tag beyond projections.

18 Jun 2014

New vaccine reprograms pancreatic tumors and makes them vulnerable to immunotherapy

Researchers at the Johns Hopkins Kimmel Cancer Center have developed and tested a vaccine that triggered the growth of immune cell nodules within pancreatic tumors, essentially reprogramming these intractable cancers and potentially making them vulnerable to immune-based therapies.

18 Jun 2014

Novogen, CanTx believe Intra-Peritoneal Trx-1 could be utilized as first-line therapy for ovarian cancer

Australian oncology drug development company Novogen Limited and CanTx Inc., its joint venture with Yale University, today announced the success of proof-of-concept pre-clinical studies confirming the potency of experimental drug, Trx-1, in the treatment of primary ovarian cancer when delivered into the peritoneal cavity.

18 Jun 2014

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with Selecta Biosciences for pegsiticase (Uricase PEG-20), a pegylated recombinant uricase from candida utilis.

18 Jun 2014

Scientists demonstrate that proteins in urine play important role in stress incontinence

Incontinence is the world's most common chronic condition. Around ten per cent of Austrians are affected by it. However the problem continues to be a taboo subject: two out of three sufferers do not talk about it, preventing access to successful treatment.

18 Jun 2014

Wayne State researchers to study how exposures to stressors impact human health in Detroit

With over $2.4 million in new federal funding, Wayne State University researchers, regional collaborators at Henry Ford Health System, the University of Michigan and Michigan State University, and community partners will study how exposures to stressors that are prevalent in the urban industrialized environment — both chemical and non-chemical — impact human health in Detroit and beyond.

18 Jun 2014

Pfizer and Cellectis enter into global strategic collaboration to develop CAR-T immunotherapies

Pfizer Inc. and Cellectis today announced that they have entered into a global strategic collaboration to develop Chimeric Antigen Receptor T-cell (CAR-T) immunotherapies in the field of oncology directed at select targets.

18 Jun 2014

Researchers discover that genetic pathway could slow spread of ovarian cancer

University of Adelaide research into the origins of ovarian cancer has led to the discovery of a genetic pathway that could slow the spread of the cancer.

18 Jun 2014

New tool helps doctors talk to dying patients and families who are praying for miracle

Cancer clinicians and a chaplain at the Johns Hopkins Kimmel Cancer Center have developed a new tool to help doctors, nurses and other health care providers talk to dying patients and families who are, literally, praying for a miracle.

17 Jun 2014

Protein test predicts NSCLC survival benefit for chemotherapy over erlotinib

Italian study results confirm that a multivariate serum protein test predicts improved survival after treatment with chemotherapy versus erlotinib for non-small-cell lung cancer, but only among patients who are likely to have a poor outcome with the latter treatment type.

16 Jun 2014

Survival differences after docetaxel, erlotinib are EGFR dependent

Results from the DELTA trial indicate no significant differences in progression-free or overall survival after treatment with docetaxel versus erlotinib in non-small-cell lung cancer patients unselected for their epidermal growth factor receptor mutation status.

16 Jun 2014

Symbion and Surgery Partners sign definitive merger agreement

Surgery Center Holdings Inc. ("Surgery Partners" or "The Company"), a portfolio company of H.I.G. Capital, LLC ("H.I.G."), and Symbion Holdings Corporation ("Symbion"), a portfolio company of Crestview Partners, have announced that they have entered into a definitive merger agreement under which Surgery Partners will acquire 100% of the stock of Symbion for a total purchase price of $792 million.

16 Jun 2014

Trovagene enters into clinical collaboration with Dana-Farber Cancer Institute

Trovagene, Inc. today announced that it has entered into a clinical collaboration with Dana-Farber Cancer Institute to investigate the utility of quantitative urine-based mutation detection and the ability to monitor tumor mutation burden and treatment response over time in metastatic melanoma patients.

16 Jun 2014

Oncology News and Research

Further Reading

Takeda decides to terminate development of orteronel for prostate cancer

BIND Therapeutics inks research agreement with Roche to discover novel nanomedicines

African American women with invasive breast cancer less likely to receive invasive technique

NCCN Reimbursement Resource App now available for patients and caregivers

Generic drug delays cost U.S. payers millions

Researchers develop device that spots lung cancer

Janssen signs license agreement with Vertex to develop, commercialize VX-787 for influenza A treatment

First Edition: June 18, 2014

New vaccine reprograms pancreatic tumors and makes them vulnerable to immunotherapy

Novogen, CanTx believe Intra-Peritoneal Trx-1 could be utilized as first-line therapy for ovarian cancer

3SBio signs exclusive license agreement with Selecta Biosciences for pegsiticase

Scientists demonstrate that proteins in urine play important role in stress incontinence

Wayne State researchers to study how exposures to stressors impact human health in Detroit

Pfizer and Cellectis enter into global strategic collaboration to develop CAR-T immunotherapies

Researchers discover that genetic pathway could slow spread of ovarian cancer

New tool helps doctors talk to dying patients and families who are praying for miracle

Protein test predicts NSCLC survival benefit for chemotherapy over erlotinib

Survival differences after docetaxel, erlotinib are EGFR dependent

Symbion and Surgery Partners sign definitive merger agreement

Trovagene enters into clinical collaboration with Dana-Farber Cancer Institute

Event guide: The 9th DDR Inhibitors Summit 2026 eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News